Home › Funds › Millennium Management › QNCX
Millennium Management position in QNCX
QUINCE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)70.78K sh
Reported value held$1.29M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 35.57K | $3.26M | New |
| Q4 2021 | 756.68K | $9.55M | Add |
| Q1 2022 | 66.17K | $410.00K | Reduce |
| Q2 2022 | 345.41K | $767.00K | Add |
| Q3 2022 | 457.99K | $609.00K | Add |
| Q4 2022 | 595.80K | $380 | Add |
| Q1 2023 | 248.01K | $387 | Reduce |
| Q2 2023 | 61.41K | $92.42K | Reduce |
| Q3 2023 | 59.93K | $67.12K | Reduce |
| Q4 2023 | 59.45K | $62.42K | Reduce |
| Q1 2024 | 53.68K | $56.90K | Reduce |
| Q2 2024 | 36.57K | $27.43K | Reduce |
| Q2 2025 | 110.68K | $182.62K | New |
| Q3 2025 | 1.39M | $2.26M | Add |
| Q4 2025 | 1.19M | $3.99M | Reduce |
| Q1 2026 | 2.50M | $253.88K | Add |
| Q2 2026 | 70.78K | $1.29M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding QNCX
- Balyasny Asset Management 69.97K sh · $12.56M · Q2 2026
- Vanguard Group 2.08M sh · $6.98M · Q4 2025
- UBS Group AG 4.73K sh · $86.04K · Q2 2026
- Morgan Stanley 4.08K sh · $74.29K · Q2 2026
- BlackRock Inc 1.70K sh · $30.96K · Q2 2026
- Wells Fargo & Co 10 sh · $182 · Q2 2026
- JPMorgan Chase & Co 2 sh · $2 · Q2 2026